Dr. Paul Abrahams – Director

Dr. Abrahams is a medical doctor by training and subsequently read for an MBA at the University of Oxford. He has co-founded and managed several start-up businesses in the healthcare, biotech and medical device space and currently focuses on the commercialisation of new technologies in the broader life sciences sector. Paul established the Aloe Ferox Company following the sale of Mbuyu Biotech, of which he was MD, in 2006.

Heather manages the day-to-day operations of Bioventures and represents the fund as a shareholder in AFC. Heather received her PhD from the University of Natal (Durban) in 1995 and has five years research and lecturing experience post PhD. After completing her MBA (University of Cape Town) Heather joined Gensec Bank as a Strategist in their Internationalisation Division where she was involved in international acquisitions. She was instrumental in setting up Bioventures and raising the Fund.

Vuyi is the Bioprocessing Portfolio Manager for BioPAD, an investor and shareholder in AFC.

This highly qualified team is committed to providing safe, natural and high quality products through its patented biotechnological processes. By utilizing a plant indigenous only to the Eastern Cape region of South Africa, the team at the Aloe Ferox Company appreciate being able to meet their social responsibility, due to the fact that the harvesting of the Aloe Ferox plant benefits and supports the local community by providing continuous, sustainable employment within that region as well as at the manufacturing plant.